BRITS have been warned as a deadly bacteria that kills one in 10 sufferers has spiked in the UK. Cases of the “worst diarrhoea ever” are rising – here are three symptoms to watch … ...

People with ulcerative colitis are susceptible to an infection from a bacterium called Clostridioides difficile, or C. diff. Here’s what to do if you think you have it.

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence ...

Study finds traditional fecal transplant outperforms new pill in severe C. diff. cases by Kendall Daniels Rovinsky, University of North Carolina at Chapel Hill School of Medicine ...

SAN DIEGO — Administration of Rebyota by colonoscopy appears safe and effective among adults with recurrent Clostridioides difficile infection, according to results from the CDI-SCOPE trial ...

The bacterium Clostridium difficile — otherwise known as C. diff — spreads within intensive care units more than three times as much as previously thought, according to a study published on ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in Phase 2. Data expected in 2025.

C. diff has a high rate of recurrence. Read more to find out why recurrence happens, who is most at risk, and how to reduce the risk of recurrence.

The Food and Drug Administration must act so patients with refractory C. difficile infection can access lifesaving fecal transplants.

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.